• Ar
  • Es
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Feature
  • Videos
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Feature
Videos
Infographs
In Pictures
  1. Home
  2. News
  3. Health
  4. US FDA approves AstraZeneca's lung cancer drugs
Health

US FDA approves AstraZeneca's lung cancer drugs

  • By Al Mayadeen English
  • Source: Agencies
  • 12 Nov 2022 22:46

AstraZeneca says that the US Food and Drug Administration (FDA) has approved its lung cancer drugs, Imfinzi and Imjudo, which improve overall survival (OS) by 25% compared to chemotherapy alone.

  • U.S. FDA Approves AstraZeneca's Lung Cancer Drugs
    U.S. FDA Approves AstraZeneca's Lung Cancer Drugs

Drugmaker AstraZeneca (AZN.L) said on Friday that the US Food and Drug Administration (FDA) has approved Imfinzi and Imjudo, its lung cancer drugs, when used along with chemotherapy for treatment of adults with stage IV non-small cell lung cancer (NSCLC).

According to AstraZeneca, "Patients treated with a limited course of five cycles of the anti-CTLA-4 antibody Imjudo added to Imfinzi plus four cycles of platinum-based chemotherapy experienced a 23% reduction in the risk of death versus a range of chemotherapy options."

"An estimated 33% of patients were alive at two years versus 22% for chemotherapy. This treatment combination also reduced the risk of disease progression or death by 28% compared to chemotherapy alone," AstraZeneca published on its website.

"Updated results from the POSEIDON Phase III trial after approximately four years of follow-up presented at the European Society of Medical Oncology (ESMO) Congress 2022 and published in the Journal of Clinical Oncology demonstrated sustained survival benefit, improving overall survival (OS) by 25% compared to chemotherapy alone."

AstraZeneca explained that "an estimated 25% of patients treated with the combination" lived at three years in comparison with only "13.6% for those treated with chemotherapy alone."

"The safety profile for Imjudo plus Imfinzi and chemotherapy was consistent with the known profiles of each medicine, and no new safety signals were identified," AstraZeneca added.

Read: New cancer treatment offers hope to patients out of options
 

  • AstraZeneca
  • Cancer
  • Food and Drug Administration (FDA)
  • cancer treatment
  • cancer research

Trending Now

All
The breakthrough could enable surgeons to be more effective in surgery by lighting up cancer cells

Light therapy to become major cancer treatment

Most Read

Haaretz

Mossad agent killed in Italy part of anti-Iran mission: Israeli media

  • Europe
  • 3 Jun
In this image released by the Italian firefighters, a helicopter searches for missing passengers after a tourist boat capsized in a storm on Italy's Lago Maggiore in the northern Lombardy region, May 28, 2023 (AP)

Top Israeli intelligence official dead in Italy: Israeli media

  • Europe
  • 29 May
US linguist Noam Chomsky, who was among 550 academics who signed the petition calling on Glasgow University to respect free speech (AFP)

Chomsky: EU will deindustrialize if it abides by US-run world order

  • Europe
  • 31 May
In Ukraine, is the US facing its own Suez moment? Its decline as an imperial power has been developing over decades. It has won small wars (Panama, Grenada) but has lost the big ones.

America’s Suez moment?

  • Opinion
  • 30 May

Read this

All
A 3D printed miniature oil pump jack is placed in front of a plummeting stock graph with OPEC's logo, April 14 2020. (Reuters)
MENA

Oil production cut proposals stir in-house tensions within OPEC

  • Today
World intelligence heads hold secret meeting in Singapore: Reuters
Asia Pacific

World intelligence heads hold secret meeting in Singapore: Reuters

  • Today
Florida hit by seaweed full of flesh-eating bacteria
US & Canada

Seaweed full of flesh-eating bacteria swarm Florida beaches

  • Today
The Engineered Arts Ameca humanoid robot with artificial intelligence is demonstrated during the consumer electronics show in 2023 in US. (AFP)
US & Canada

Human extinction by AI ‘not that concerning… at least for now': Expert

  • Today
Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS